Investigational · not FDA approved

Editorially reviewed · Last updated June 2026 · How we review

Can You Build Muscle on Retatrutide?

Part of Retatrutide — All Topics.

Can You Build Muscle on Retatrutide? The Testosterone Confound in Viral Transformations

Search "retatrutide results" and you will find dramatic before-and-after posts: people who lost a third of their body weight and emerged visibly muscular, lean, and vascular — not "deflated." It is tempting to conclude that retatrutide builds or preserves muscle in a way other weight-loss drugs do not.

It does not. Retatrutide is a weight-loss drug, not an anabolic one. The striking physiques in the most-shared transformations are almost always built by what else is in the protocol — most often testosterone and growth-hormone peptides — while retatrutide does the job it was designed for: driving the scale down. This page separates the two, using one of the most-viewed transformation posts as a worked example.

A worked example: the viral 7-month transformation

In June 2026, a 7-month retatrutide transformation log went viral on X, viewed more than 400,000 times. The headline numbers were genuinely impressive:

Start (Dec 2025): 215 lb, ~21% body fat, 38" waist. Now: 178 lb, 7.9% body fat, 29.25" waist. Roughly 1.4 lb/week across the full run.

To the poster's credit, he did not present this as a clean drug result. Buried in the same thread, he listed every lever he was pulling — and explicitly noted: "This was not a Reta clinical trial. It was one piece of a full biohacking protocol." That transparency is exactly what makes it a useful teaching case. The full stack:
CompoundReported useWhat it primarily does
Retatrutide2 mg start, ran 1.5–2.5 mg/weekAppetite suppression and fat loss — the weight-loss driver
Testosterone200 mg/week, later 180 mg/weekBuilds and preserves lean mass (dose-dependent)
HCG500 IU twice weeklyMaintains testicular function alongside testosterone
CJC-1295 / IpamorelinCycledGrowth-hormone secretagogues — raise GH/IGF-1, support lean mass
Tesamorelin3-week blockGH-releasing analog — reduces visceral fat, supports lean mass
Tadalafil6 mg, 3×/weekVasodilation (blood flow / pumps); not anabolic

Read that table and the "muscular at 7.9% body fat" outcome stops being mysterious. Four of the six compounds act on muscle and growth-hormone pathways. Retatrutide is not one of them.

What retatrutide actually does to muscle

Retatrutide is a triple agonist (GIP, GLP-1, glucagon) that produces weight loss by suppressing appetite and increasing energy expenditure. Like all weight loss — from any drug, surgery, or diet — some of the weight lost is lean tissue, not just fat.
In the Phase 2 DXA sub-study (Coskun et al., Lancet Diabetes & Endocrinology 2025), fat accounted for roughly 62.0% to 69.3% of total weight lost across the effective retatrutide doses — meaning 30.7% to 38.0% came from lean mass. That ratio is comparable to semaglutide (~39% lean in STEP 1) and tirzepatide (~25–33% lean in SURMOUNT-1). Retatrutide does not preserve muscle better than other GLP-1-based drugs, and it has no mechanism to build it.
So on retatrutide alone, the honest expectation is: you lose fat, you lose some muscle along with it, and a disciplined person with resistance training and high protein intake keeps that lean loss toward the lower end of the range. You do not come out the other side more muscular than you went in. For the full body-composition data, see Does Retatrutide Cause Muscle Loss?.

The testosterone confound

This is the part the transformation photos hide. Testosterone, especially at the high-replacement-to-supraphysiological doses common in biohacking protocols, increases lean mass on its own — independent of training or diet.

The clearest evidence is the Bhasin testosterone dose-response trial (Am J Physiol Endocrinol Metab, 2001), which held energy and protein intake constant and gave healthy men graded weekly testosterone doses for 20 weeks:
Weekly testosterone doseFat-free mass change over 20 weeks
125 mg+3.4 kg
300 mg+5.2 kg
600 mg+7.9 kg
Fat-free mass rose dose-dependently, and the change correlated tightly with testosterone concentration. The viral example's 200 mg/week sits between the 125 mg and 300 mg arms — so roughly 4 to 5 kg of lean mass gain is expected from the testosterone alone, before counting the additional GH/IGF-1 support from CJC-1295, ipamorelin, and tesamorelin.

Put the two drugs side by side and the division of labor is clean:

OutcomeDriven byVerdict
37 lb scale weight lossRetatrutide (appetite + expenditure)Reta did this
~1.4 lb/week loss rate at 1.5–2.5 mgRetatrutide — consistent with the trial curveReta did this
Muscle retention / 7.9% body fat / 'top 1%' compositionTestosterone 200 mg/week + GH peptidesThe stack did this, not reta
Vascularity / pumps in photosLow body fat + tadalafil vasodilationNot reta, not muscle
His weight-loss numbers actually validate retatrutide rather than overstate it. A ~17% total loss at an average of roughly 2 mg/week, over about 30 weeks, tracks neatly between the −8.7% (1 mg) and −17.1% (4 mg) figures from the NEJM Phase 2 trial at 48 weeks. The poster himself said reta "for sure helped with the weight loss as the main driver" — he did not claim it built the muscle.

The negatives, by contrast, are retatrutide

If you want to know what retatrutide alone contributed to this protocol, look at the side effects — because those track the drug, not the stack. The same log reported:

  • Resting heart rate climbing from the mid-50s to the low-70s, which persisted even after dropping to 1 mg
  • Decreased sleep quality
  • A flat, apathetic mood when the dose was pushed to 2.5 mg
The heart-rate signal is textbook retatrutide. The NEJM Phase 2 trial documented dose-dependent increases in heart rate that peaked at 24 weeks, and elevated resting heart rate is one of the most consistently reported retatrutide effects. These were significant enough that the poster cited them as his reason to switch off retatrutide entirely. For the full safety picture, see Retatrutide Side Effects.

What this means if you are considering retatrutide

  • If you are not on testosterone or GH peptides, do not expect a "transformation-post" physique. Those results are a stacked protocol, not a retatrutide result. Comparing yourself to them sets a false benchmark.
  • Retatrutide will not build muscle. Its honest job is fat loss. The best you can do for muscle on retatrutide alone is minimize lean loss — through resistance training and high protein intake — not add to it.
  • The dramatic body-composition numbers in viral posts usually have an anabolic agent behind them, even when it is not in the headline. Read the full thread before you read the photos.
  • Stacking retatrutide with testosterone is a medical decision, not a hack. It combines a drug that raises heart rate with weight loss, supraphysiological hormone dosing, and injectable peptides — and is well outside any studied regimen. None of the compounds above are FDA-approved for this use.

Frequently Asked Questions

Does retatrutide build muscle?

No. Retatrutide is a triple-agonist weight-loss drug with no anabolic mechanism. Like all weight loss, retatrutide treatment involves losing some lean mass alongside fat — in the Phase 2 DXA sub-study, roughly 30.7% to 38.0% of total weight lost was lean tissue. Resistance training and high protein intake can minimize that loss, but retatrutide itself does not add muscle.

Why do retatrutide transformations online look so muscular?

Because the most dramatic transformations are usually running a full stack, not retatrutide alone. Testosterone at high-replacement-to-supraphysiological doses increases fat-free mass dose-dependently (roughly +3 to +8 kg over 20 weeks in controlled trials), and growth-hormone peptides like CJC-1295, ipamorelin, and tesamorelin add further lean-mass support. Retatrutide drives the fat loss; the other compounds build the physique.

Can you take retatrutide with testosterone (TRT)?

People do, but it is well outside any studied regimen and combines compounding cardiovascular considerations — retatrutide raises resting heart rate, and supraphysiological testosterone carries its own risks. Neither drug is FDA-approved for weight management in this combination. This is a decision for a qualified physician, not something to copy from a transformation post.

Does retatrutide cause muscle loss?

Some, like every weight-loss method. The Phase 2 DXA sub-study found total lean mass decreased by up to 12.5% at the 8 mg dose, with lean tissue making up roughly 30.7% to 38.0% of total weight lost — comparable to semaglutide and tirzepatide. See Does Retatrutide Cause Muscle Loss? for the full data and how to preserve lean mass.

How much of a viral retatrutide result is actually the drug?

The scale weight loss is genuinely retatrutide — loss rates of around 1 to 1.5 lb/week at low doses match the published trial curves. The muscularity, the very low body-fat physique, and the "preserved" or improved muscle are usually the testosterone and GH peptides. A useful rule: attribute the weight lost to retatrutide and the body composition to whatever anabolic agents are in the stack.

Sources

  • Jastreboff, A.M., et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine. DOI: 10.1056/NEJMoa2301972
  • Coskun, T., et al. (2025). Retatrutide body composition sub-study (DXA). The Lancet Diabetes & Endocrinology. Article
  • Bhasin, S., et al. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism. DOI: 10.1152/ajpendo.2001.281.6.E1172
  • Viral 7-month retatrutide transformation log (X, June 2026; over 400,000 views) — cited as an illustrative example of how multi-compound protocols confound the interpretation of single-drug results.
How we keep this honest
What this is
Educational information, not medical advice. It reports published research — it doesn’t recommend that you use, obtain, or supply anything.
Regulatory status
Retatrutide and similar peptides are investigational — not approved by the FDA or any regulator. Semaglutide and tirzepatide are prescription-only medicines, available only through a licensed prescriber.
Our standard
Every claim traces to a primary source. We label the strength of evidence and flag estimates as estimates — never as clinical fact.
No commercial ties
We don’t sell, supply, or link to suppliers of any medicine, and aren’t affiliated with any manufacturer.

Do not make decisions about your health without consulting a qualified healthcare provider. For trial enrolment, see ClinicalTrials.gov. More on how we review.

Sources

Grounded in primary sources
NEJMThe LancetJAMAFDAClinicalTrials.gov

Keep exploring

Explore all retatrutide topics →